Avanos Medical (AVNS) Misses Q2 Earnings Estimates

Company Performance - Avanos Medical reported quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share, and down from $0.34 per share a year ago, representing an earnings surprise of -5.56% [1] - The company posted revenues of $175 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.70%, compared to year-ago revenues of $171.7 million [2] - Over the last four quarters, Avanos Medical has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Avanos Medical shares have lost about 29.3% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The current status translates into a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $0.19 on revenues of $166.35 million, and for the current fiscal year, it is $0.92 on revenues of $677.14 million [7] - The outlook for the industry can materially impact the stock's performance, with the Medical - Instruments industry currently in the bottom 37% of Zacks industries [8]